A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1994
12/20/1994	US5374431 Polypeptide chains having helical structure in aqueous environments containing crosslinkable surface adherable amino acids; form insoluble matrix for adhering cells
12/20/1994	EP0650366A4 Compositions and methods for treating wounds.
12/20/1994	CA1333647C Heptapeptide analogs of somatostatin
12/20/1994	CA1333646C Biologically active lysine containing octapeptides
12/20/1994	CA1333563C Synthetic vaccine against foot and mouth disease and a process for the preparation thereof
12/18/1994	CA2126026A1 2-piperazinone compounds and their use
12/17/1994	CA2125793A1 Organic compounds
12/14/1994	EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor
12/14/1994	EP0628631A1 A phosphatidylethanolamine binding protein derived from a human glioblastoma cell line and DNA encoding it
12/14/1994	EP0628571A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion
12/14/1994	EP0628315A1 Lectin complex and probe and method for making same
12/14/1994	EP0628307A2 Methods for administering biological agents and microparticle compositions useful in these and other methods
12/14/1994	EP0628306A1 Intraocular irrigating solution containing S-(alpha,bêta-dicarboxyethyl)-glutathione
12/14/1994	EP0628168A1 Method for modulating proopiomelanocortin synthesis in a mammal
12/14/1994	EP0628078A1 Multivalent single chain antibodies
12/14/1994	EP0628057A1 Compositions and methods for the treatment of thermal injury
12/14/1994	EP0628056A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections
12/14/1994	EP0628055A1 Modified tcf
12/14/1994	EP0628054A1 Car receptors and related molecules and methods
12/14/1994	EP0628053A1 Hepatitis e virus peptide antigens and antibodies
12/14/1994	EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
12/14/1994	EP0627934A1 Early antigen for autoimmune diabetes
12/14/1994	EP0627933A1 Bystander suppression of autoimmune diseases
12/14/1994	EP0627931A1 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14
12/14/1994	EP0627930A1 Composition and method of treating hepatitis b
12/14/1994	EP0627929A1 Inhibitors of thrombosis
12/14/1994	EP0627928A1 Use of muramyl peptide for the treatment of toxicity
12/14/1994	EP0627927A1 Use of injectable biomaterials in the treatment of hemorrhoids
12/14/1994	EP0627926A1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
12/14/1994	EP0627925A1 Trypsin inhibitors
12/14/1994	EP0627924A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
12/14/1994	EP0627923A1 Therapeutic domains of von willebrand factor
12/14/1994	EP0627913A1 Facilitated oxygen delivery in conjunction with hemodilution
12/14/1994	EP0627912A1 Gels for encapsulation of biological materials
12/14/1994	EP0627911A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
12/14/1994	EP0627900A1 Use of injectable biomaterials for the repair and augmentation of the anal sphincters
12/14/1994	EP0496813B1 Liposome microreservoir composition and method
12/14/1994	EP0473689B1 Thrombus-targeted complexes of plasminogen activator and fibrin fragments
12/14/1994	EP0471030B1 Glycoprotein hormone receptor molecules
12/14/1994	EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition
12/14/1994	CN1096326A Preparing method for recomposing streptokinase
12/14/1994	CN1096222A A pharmaceutical formulation
12/14/1994	CN1096221A Substained-release preparation
12/13/1994	US5373090 Aprotinin analogues and a process for the production thereof
12/13/1994	US5373089 Oxytocin antagonist
12/13/1994	US5372997 Albumin preparation and method for preserving the same
12/13/1994	US5372942 Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
12/13/1994	US5372933 Antibody-polypeptide immunocomplex
12/13/1994	US5372812 Composition and method for acceleration of clot lysis
12/13/1994	US5372809 Antigenic matrix metalloproteinase peptides
12/13/1994	US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
12/13/1994	CA1333471C Whey protein concentrate as food supplement
12/09/1994	CA2125008A1 Peptide and dnas encoding it
12/08/1994	WO1994028391A1 Ligands for flt3 receptors
12/08/1994	WO1994028160A1 Monoclonal antibody, process for producing the same, and use thereof
12/08/1994	WO1994028157A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein
12/08/1994	WO1994028156A1 Compositions and methods for treatment of herpesvirus infections
12/08/1994	WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
12/08/1994	WO1994028152A1 Defective adenoviruses and corresponding complementation lines
12/08/1994	WO1994028151A1 Gene therapy for haemophilia
12/08/1994	WO1994028145A2 Expression of urokinase plasminogen activator inhibitors
12/08/1994	WO1994028139A1 tRNA BINDING-DEPENDENT INHIBITION OF MICROBIAL PATHOGEN GROWTH
12/08/1994	WO1994028137A1 Regulator of contact-mediated hemolysin
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028133A1 Recombinant neu differentiation factors
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028130A1 Gene that codes for polypeptide having ability to support pre-b cell proliferation
12/08/1994	WO1994028127A1 Cancer treatment
12/08/1994	WO1994028124A1 Tnf alpha responsive element and tnf alpha induced dna-binding protein which binds to the tnf alpha responsive element
12/08/1994	WO1994028123A1 Mammals lacking expression of cd28 transgenic
12/08/1994	WO1994028122A1 Transgenic mammals lacking expression of particular cd45 isoforms
12/08/1994	WO1994028120A1 Process for the sterilization of biological compositions and the product produced thereby
12/08/1994	WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
12/08/1994	WO1994028024A1 Carbohydrate-modified polymer conjugates with erythropoietic activity
12/08/1994	WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use
12/08/1994	WO1994028022A1 Novel protein having avidity with heparin-binding growth factor
12/08/1994	WO1994028019A1 Human calcium sensor
12/08/1994	WO1994028017A1 Human mutant tissue factor compositions useful as tissue factor antagonists
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994028015A1 Lhrh antagonists
12/08/1994	WO1994028014A2 Peptide inhibitors of urokinase receptor activity
12/08/1994	WO1994028013A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock
12/08/1994	WO1994028012A1 Hydroxamate inhibitors of endothelin converting enzyme
12/08/1994	WO1994028009A1 Fragments of neurofibromin (nf1) and method to reverse activated ras induced malignant transformation in mammalian cells
12/08/1994	WO1994027958A1 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
12/08/1994	WO1994027643A1 Envelope fusion vectors for use in gene delivery
12/08/1994	WO1994027641A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	WO1994027640A1 Method of treatment and prevention of immune complex-induced lung injury
12/08/1994	WO1994027639A1 Methods for treating post-exposure rabies and anti-rabies compositions
12/08/1994	WO1994027638A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/08/1994	WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
12/08/1994	WO1994027635A1 Compositions and methods for treating cancer and hyperproliferative disorders
12/08/1994	WO1994027633A1 Bandage for continuous application of biologicals
12/08/1994	WO1994027632A1 Cell growth regulators
12/08/1994	WO1994027631A1 Modified factor vii
12/08/1994	WO1994027630A1 Cross-linked gelatin gel preparation containing basic fibroblast growth factor
12/08/1994	WO1994027629A1 Method to control appetite and treat obesity
12/08/1994	WO1994027628A1 Enteral nutritional product
12/08/1994	WO1994027627A1 Hemoregulatory peptides
12/08/1994	WO1994027626A1 Method for decreasing calcium uptake by cells

1 ... 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 ... 3163